Nevertheless, the findings are noteworthy as they, for the first time, suggest a direct link between the in situ vascular presence of SARS-CoV-2 and the onset of coagulopathies, proposing an alteration in PROS1 expression as a potential key contributor to SARS-CoV-2-associated coagulation disorders. The gene discussed is PROS1; the disease is blood coagulation disease.